Condition: Metabolic Dysfunction-Associated Steatotic Liver Disease · Non-alcoholic Fatty Liver Disease · Nonalcoholic Fatty Liver Disease · Sponsor: Merck Sharp & Dohme LLC
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
This study will evaluate the effect of efinopegdutide administration once every 2 weeks (Q2W) versus once weekly (Q1W) on mean relative reduction from baseline in liver fat content (LFC) after 28 weeks, as well as the safety and tolerability of the different regimens of efinopegdutide.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: The main inclusion criteria include but are not limited to the following: * Has body mass index (BMI) ≥25 kg/m\^2 (≥23 kg/m\^2 for Asian participants) AND has stable weight, defined as ≤5% gain or loss of body weight for at least 3 months before screening * Has no history of type 2 diabetes mellitus (T2DM) OR has a history of T2DM with a glycated hemoglobin (A1C) ≤9% AND the T2DM is controlled by diet or stable doses of oral antihyperglycemic agents (AHAs) Exclusion Criteria: The main exclusion criteria include but are not limited to the following * Has a history or evidence of chronic liver disease other than Metabolic dysfunction-associated steatotic liver disease (MASLD) or Metabolic dysfunction-associated steatohepatitis (MASH) * Has evidence of decompensated liver disease including, but not limited to ascites, esophageal or gastric variceal bleeding, hepatocellular carcinoma, hepatic encephalopathy, splenomegaly, or spontaneous bacterial peritonitis * Has a history of pancreatitis * Has a history of type 1 diabetes mellitus (T1DM), diabetic ketoacidosis, or diabetes secondary to pancreatectomy. * Has symptomatic hyperglycemia * Has a history of a bariatric surgical procedure ≤5 years before Screening or a known clinically significant gastric emptying abnormality * Has a history of obesity with a known secondary cause * Has significant systemic or major illnesses, including recent (≤6 months before Screening) onset of events of congestive heart failure, unstable angina, myocardial infarction, arterial revascularization, stroke, or transient ischemic attack * Is unable to have Magnetic Resonance Imaging-Estimated Proton Density Fat Fraction (MRI-PDFF) due to: Claustrophobia to a degree that prevents tolerance of an MRI-PDFF scanning procedure. Note: Sedation is permitted, at the discretion of the investigator; Metallic implants that prevent MRI-PDFF examination; Exceeds the body habitus and/or weight limitations for the MRI scanner
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| The Institute for Liver Health II dba Arizona Clinical Trial-The Institute for Liver Health ( Site 0 | Chandler, Arizona, United States | — |
| The Institute for Liver Health II dba Arizona Liver Health - Peoria ( Site 0224) | Peoria, Arizona, United States | — |
| Arizona Liver Health ( Site 0211) | Tucson, Arizona, United States | — |
| Del Sol Research Management, LLC ( Site 0209) | Tucson, Arizona, United States | — |
| Om Research LLC ( Site 0207) | Camarillo, California, United States | — |
| Gastroenterology and Liver Institute ( Site 0263) | Escondido, California, United States | — |
| Velocity Clinical Research, Gardena ( Site 0235) | Gardena, California, United States | — |
| Velocity Clinical Research, Huntington Park ( Site 0210) | Huntington Park, California, United States | — |
| California Liver Research Institute ( Site 0216) | Pasadena, California, United States | — |
| Acclaim Clinical Research ( Site 0241) | San Diego, California, United States | — |
| Velocity Clinical Research, Santa Ana ( Site 0250) | Santa Ana, California, United States | — |
| Velocity Clinical Research, Panorama City ( Site 0228) | Van Nuys, California, United States | — |
+ 27 more locations — full list on the registry record.
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.